Most clinicians feel DES exposure does not contraindicate OC use.  [electronic resource] 

 -  Contraceptive technology update  Oct 1987 
 - 127-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0274-726X 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biology<br/>Contraception<br/>Contraceptive Agents<br/>Contraceptive Agents, Female<br/>Contraceptives, Oral<br/>Contraceptives, Oral, Combined<br/>Data Collection<br/>Delivery of Health Care<br/>Diethylstilbestrol<br/>Disease<br/>Endocrine System<br/>Estrogens<br/>Family Planning Services<br/>Health<br/>Health Personnel<br/>Hormones<br/>Neoplasms<br/>Physicians<br/>Physiology<br/>Reproductive Control Agents<br/>Research<br/>Sampling Studies<br/>Uterine Cervical Neoplasms<br/>Vaginal Neoplasms